Sunscreen product recalled for microbial contamination nationwide
SHEET SPF 30 Mineral sunscreen is being recalled for microbial contamination. The product was distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall for microbial contamination of a topical OTC drug product. No illnesses or injuries have been reported, and the specific pathogen is not identified. Per the rubric, low-risk contamination without reported illness warrants a score of 2 (Moderate).
Plain-English summary
Vivier Pharma, Inc. is recalling SHEET SPF 30 Mineral sunscreen due to microbial contamination of the non-sterile product. The recalled product is the 60 ml (2 fl oz) size with lot number 91771 and expiration date 09/2025 (NDC 67226-2232-6). Approximately 3,476 units were distributed nationwide within the United States.
The product has been found to contain microbial contamination. Consumers who have purchased this lot should stop using it.
The recalled product
- Product
- SHEET SPF 30 MINERAL (TITANIUM DIOXIDE, ZINC OXIDE)
- Brand
- SHEET SPF 30 MINERAL
- Manufacturer
- Vivier Pharma, Inc.
- Category
- Drug — Topical Sunscreen
- Hazard
- Affected units
- 3,476
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 91771
- Exp. Date 09/2025
UPCs (1)
- 0696163800337
Distribution
Distributed nationwide across the United States.
Related recalls
Same hazard · microbial contamination
See all →- CriticalVictory Medical Center Pharmacy Recalls Glutathione Vials Due to Contamination
FDA (Drugs) · 2026-08-19
- HighMedline Medical Convenience Kits Recalled Due to Potential Bacillus Contamination
FDA (Devices) · 2026-07-29
- HighMedline Convenience Kits Recalled Over Bacillus Contamination
FDA (Devices) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SeverePemetrexed for Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15